Paul Canning

1.3k total citations
33 papers, 1.0k citations indexed

About

Paul Canning is a scholar working on Ophthalmology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Paul Canning has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Ophthalmology, 10 papers in Molecular Biology and 6 papers in Clinical Biochemistry. Recurrent topics in Paul Canning's work include Retinal Diseases and Treatments (11 papers), Advanced Glycation End Products research (6 papers) and Glaucoma and retinal disorders (5 papers). Paul Canning is often cited by papers focused on Retinal Diseases and Treatments (11 papers), Advanced Glycation End Products research (6 papers) and Glaucoma and retinal disorders (5 papers). Paul Canning collaborates with scholars based in United Kingdom, United States and Slovakia. Paul Canning's co-authors include Alan W. Stitt, Tom A. Gardiner, Norma Frizzell, Andrzej S. Januszewski, Mark E. Chachich, Suzanne R. Thorpe, Noel W. Duffy, John Baynes, Cliona Boyle and Nathan Anderson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biomaterials.

In The Last Decade

Paul Canning

31 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Canning United Kingdom 17 332 330 225 148 124 33 1.0k
J Kao United States 12 582 1.8× 760 2.3× 33 0.1× 238 1.6× 113 0.9× 12 1.6k
Haijuan Gu China 15 52 0.2× 351 1.1× 71 0.3× 78 0.5× 50 0.4× 29 866
Xiaoxia Z. West United States 14 28 0.1× 468 1.4× 83 0.4× 28 0.2× 92 0.7× 17 1.1k
Yoshiya Katsura Japan 16 39 0.1× 300 0.9× 178 0.8× 113 0.8× 20 0.2× 29 675
Zhengzhe Li China 19 52 0.2× 471 1.4× 11 0.0× 68 0.5× 83 0.7× 33 1.1k
Eduardo López Spain 13 137 0.4× 682 2.1× 10 0.0× 93 0.6× 17 0.1× 17 1.2k
Yi Song China 17 24 0.1× 696 2.1× 75 0.3× 15 0.1× 59 0.5× 38 1.1k
Haozhu Chen China 16 76 0.2× 217 0.7× 8 0.0× 197 1.3× 78 0.6× 50 928
Yunbiao Lu United States 14 32 0.1× 660 2.0× 19 0.1× 50 0.3× 133 1.1× 17 1.3k
Ying Lv China 24 23 0.1× 633 1.9× 22 0.1× 20 0.1× 384 3.1× 102 1.5k

Countries citing papers authored by Paul Canning

Since Specialization
Citations

This map shows the geographic impact of Paul Canning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Canning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Canning more than expected).

Fields of papers citing papers by Paul Canning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Canning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Canning. The network helps show where Paul Canning may publish in the future.

Co-authorship network of co-authors of Paul Canning

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Canning. A scholar is included among the top collaborators of Paul Canning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Canning. Paul Canning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Augustine, Josy, Thomas Friedel, Clinton T. Baldwin, et al.. (2025). Scavenging acrolein with 2-HDP preserves neurovascular integrity in a rat model of diabetic retinal disease. Diabetologia. 68(11). 2609–2629.
2.
O’Hare, Michael, Gema Esquiva, Mary K. McGahon, et al.. (2022). Loss of TRPV2-mediated blood flow autoregulation recapitulates diabetic retinopathy in rats. JCI Insight. 7(18). 16 indexed citations
3.
Canning, Paul, Caroline J. Barelle, Fiona Cunningham, et al.. (2019). Pre-treatment of Endothelial Colony Forming Cells (ECFCs) with a novel anti-oxidant enhances their vasoregenerative potential.. Investigative Ophthalmology & Visual Science. 60(9). 1663–1663. 1 indexed citations
4.
Cunningham, Fiona, Paul Canning, Tine Van Bergen, et al.. (2019). Placental growth factor (PlGF) induced signalling regulates barrier properties of the retinal pigment epithelium (RPE). Investigative Ophthalmology & Visual Science. 60(9). 1932–1932.
5.
Graham, Sarah, et al.. (2019). Influential factors in patient uptake of influenza vaccination during pregnancy; a survey-based audit in a tertiary hospital setting.. PubMed. 132(1506). 42–51. 6 indexed citations
6.
Canning, Paul, et al.. (2019). ARA290 (cibinetide) treatment confers neuroprotective effects in diabetic retinopathy, through modulation of inflammatory mediators.. Investigative Ophthalmology & Visual Science. 60(9). 2720–2720. 1 indexed citations
7.
O'Leary, Olivia, Paul Canning, Emma Reid, et al.. (2019). The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic. Experimental Eye Research. 182. 144–155. 16 indexed citations
8.
Ashraf, Sadaf, Paul Canning, Ileana Micu, et al.. (2019). CAMKII as a therapeutic target for growth factor-induced retinal and choroidal neovascularisation. JCI Insight. 4(6). 12 indexed citations
9.
Canning, Paul, Josephine V. Glenn, Vivien E. Prise, et al.. (2013). Lp-PLA 2 is a potential therapeutic target in diabetic macula edema. Investigative Ophthalmology & Visual Science. 54(15). 4613–4613. 2 indexed citations
10.
Guo-Parke, Hong, Paul Canning, Isobel Douglas, et al.. (2013). Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium. American Journal of Respiratory and Critical Care Medicine. 188(7). 842–851. 75 indexed citations
11.
Zholos, Alexander V., Mark Williams, Paul Canning, et al.. (2012). Development of primary human nasal epithelial cell cultures for the study of cystic fibrosis pathophysiology. American Journal of Physiology-Cell Physiology. 303(11). C1173–C1179. 42 indexed citations
12.
McDonald, Louise, Denise McDonald, Paul Canning, et al.. (2009). Effects of an Endothelin Receptor Antagonist on a Model of Hypertensive Retinopathy. Ophthalmic Research. 43(2). 99–107. 7 indexed citations
13.
Canning, Paul, Josephine V. Glenn, Daniel K. Hsu, et al.. (2007). Inhibition of Advanced Glycation and Absence of Galectin‐3 Prevent Blood‐Retinal Barrier Dysfunction during Short‐Term Diabetes. Journal of Diabetes Research. 2007(1). 51837–51837. 75 indexed citations
14.
Hughes, John M., Esther J. Kuiper, Ingeborg Klaassen, et al.. (2007). Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina. Diabetologia. 50(5). 1089–1098. 65 indexed citations
15.
Brankin, Brenda, Matthew Campbell, Paul Canning, Tom A. Gardiner, & Alan W. Stitt. (2005). Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium. Experimental Eye Research. 81(1). 22–31. 25 indexed citations
16.
Curran, Kevin, et al.. (2005). Online Gaming. American Journal of Applied Sciences. 2(3). 622–625. 1 indexed citations
17.
Stitt, Alan W., Steven J. Hughes, Paul Canning, et al.. (2004). Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia. 47(10). 1735–1746. 47 indexed citations
18.
19.
Cross, L. J. M., Alexandra E. Irvine, Terence R.J. Lappin, et al.. (2001). Peptide Leucine Arginine, a Potent Immunomodulatory Peptide Isolated and Structurally Characterized from the Skin of the Northern Leopard Frog, Rana pipiens. Journal of Biological Chemistry. 276(13). 10145–10152. 41 indexed citations
20.
Duggan, Brian, Perry Maxwell, John D. Kelly, et al.. (2001). THE EFFECT OF ANTISENSE BCL-2 OLIGONUCLEOTIDES ON BCL-2 PROTEIN EXPRESSION AND APOPTOSIS IN HUMAN BLADDER TRANSITIONAL CELL CARCINOMA. The Journal of Urology. 166(3). 1098–1105. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kao Breakdown of academic impact, for papers by Haijuan Gu Breakdown of academic impact, for papers by Xiaoxia Z. West Breakdown of academic impact, for papers by Yoshiya Katsura Breakdown of academic impact, for papers by Zhengzhe Li Breakdown of academic impact, for papers by Eduardo López Breakdown of academic impact, for papers by Yi Song Breakdown of academic impact, for papers by Haozhu Chen Breakdown of academic impact, for papers by Yunbiao Lu Breakdown of academic impact, for papers by Ying Lv
Rankless by CCL
2026